Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continued Efficacy of SC Apomorphine in Late-Stage Parkinson's Disease
NCT00200525Phase 3Completed
- Sponsor
- Viatris
- Start
- Jul 2001
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of apomorphine in Parkinson's disease (PD), sponsored by Viatris. Started Jul 2001; status: completed.
02
Drugs
apomorphine
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00200525.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00200525.